Correction to: Experimental & Molecular Medicine https://doi.org/10.1038/s12276-023-01036-7, published online 03 July 2023
After online publication of this article, the authors noticed an error in the Acknowledgements section.
The correct statement of this article should have read as below.
“This study was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Korean government (NRF 2021M3A9E4021818 and NRF-2022M3A9G8082639), the NRF grant awarded by the Korean government (NRF-2022R1A2C2007300) and a faculty research grant of Yonsei University College of Medicine (6-2021-0080)”
The authors apologize for any inconvenience caused.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Baek, JH., Kim, M.S., Jung, H.R. et al. Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Exp Mol Med 56, 2324 (2024). https://doi.org/10.1038/s12276-024-01343-7
Published:
Issue date:
DOI: https://doi.org/10.1038/s12276-024-01343-7
